TetraLogic Pharmaceuticals Corporation

TLOGOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$979

P/E Ratio—

52W High$0.001

52W Low$0.00004

Avg Volume178

Open$0.00

Beta4.06

Earnings Financials Revenue

TetraLogic Pharmaceuticals Corporation (TLOG) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

TLOG · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2016Report Date: Nov 3, 2016

EPS Actual

-$0.08

Revenue

—

Fiscal Period

Q4 FY2016

FY ends December

Report Date

Nov 3, 2016

After Market Close

TLOG reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q4 FY2016	Nov 3, 2016	—	-$0.08	—	—	—	—
— Q3 FY2016	Aug 11, 2016	—	-$0.22	—	—	—	—
— Q2 FY2016	May 4, 2016	—	-$0.45	—	—	—	—
— Q1 FY2016	Mar 16, 2016	—	-$0.76	—	—	—	—
— Q4 FY2015	Nov 4, 2015	—	-$0.34	—	—	—	—
— Q3 FY2015	Aug 5, 2015	—	-$0.32	—	—	—	—
— Q2 FY2015	May 14, 2015	—	-$0.25	—	—	—	—
— Q1 FY2015	Feb 26, 2015	—	-$0.38	—	—	—	—

Q4 FY2016

Nov 3, 2016

EPS Actual

-$0.08

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2016

Aug 11, 2016

EPS Actual

-$0.22

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2016

May 4, 2016

EPS Actual

-$0.45

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2016

Mar 16, 2016

EPS Actual

-$0.76

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2015

Nov 4, 2015

EPS Actual

-$0.34

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2015

Aug 5, 2015

EPS Actual

-$0.32

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2015

May 14, 2015

EPS Actual

-$0.25

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2015

Feb 26, 2015

EPS Actual

-$0.38

EPS Est.

—

EPS Surpr.

—

Revenue

—

No analyst estimates available for TLOG.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q4 FY2016	Nov 3, 2016	—	$0.13	$0.11	-11.84%
— Q3 FY2016	Aug 11, 2016	—	$0.22	$0.23	+3.19%
— Q2 FY2016	May 4, 2016	—	$0.29	$0.28	-3.45%
— Q1 FY2016	Mar 16, 2016	—	$0.21	$0.19	-9.48%
— Q4 FY2015	Nov 4, 2015	—	$1.84	$1.83	-0.54%
— Q3 FY2015	Aug 5, 2015	—	$2.71	$2.50	-7.75%
— Q2 FY2015	May 14, 2015	—	$2.53	$2.42	-4.35%
— Q1 FY2015	Feb 26, 2015	—	$4.87	$4.83	-0.82%

Q4 FY2016-11.84%

Report Date

Nov 3, 2016

EPS Beat/Miss

—

Price Before

$0.13

Price After

$0.11

Q3 FY2016+3.19%

Report Date

Aug 11, 2016

EPS Beat/Miss

—

Price Before

$0.22

Price After

$0.23

Q2 FY2016-3.45%

Report Date

May 4, 2016

EPS Beat/Miss

—

Price Before

$0.29

Price After

$0.28

Q1 FY2016-9.48%

Report Date

Mar 16, 2016

EPS Beat/Miss

—

Price Before

$0.21

Price After

$0.19

Q4 FY2015-0.54%

Report Date

Nov 4, 2015

EPS Beat/Miss

—

Price Before

$1.84

Price After

$1.83

Q3 FY2015-7.75%

Report Date

Aug 5, 2015

EPS Beat/Miss

—

Price Before

$2.71

Price After

$2.50

Q2 FY2015-4.35%

Report Date

May 14, 2015

EPS Beat/Miss

—

Price Before

$2.53

Price After

$2.42

Q1 FY2015-0.82%

Report Date

Feb 26, 2015

EPS Beat/Miss

—

Price Before

$4.87

Price After

$4.83

Beat Rate0 / 8 quarters

Largest Move-11.84% (Q4 FY2016)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

TetraLogic Pharmaceuticals Corporation (TLOG) most recently reported earnings on November 3, 2016 for Q4 FY2016, posting EPS of $-0.08 (in line with the analyst consensus of —). The next TLOG earnings date is expected around September 1, 2026.

Each quarter, investors track TLOG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TLOG revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

TLOG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

TLOG earnings · 4 questions

TetraLogic Pharmaceuticals Corporation's next earnings report is expected around September 1, 2026. TLOG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TLOG historically reports after market close (AMC).

TLOG earnings datewhen is TLOG earningsTLOG next earnings datewhen does TLOG report earningsTLOG earnings calendar

▸ Source: FMP · TetraLogic Pharmaceuticals Corporation SEC filings · US GAAP · TetraLogic Pharmaceuticals Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026